1. 2564 The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer. (September 2015) Authors: Van Soest, R.; Nieuweboer, A.; De Morrée, E.; Chitu, D.; Bergman, A.; Goey, H.; Bos, M.; Van der Meer, N.; Hamberg, P.; De Wit, R.; Mathijssen, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2575 Presence of androgen receptor splice variants in circulating tumor cells and response to cabazitaxel in castration-resistant prostate cancer. (September 2015) Authors: Onstenk, W.; Sieuwerts, A.; Kraan, J.; Van, M.; Nieuweboer, A.; Mathijssen, R.; Hamberg, P.; Meulenbeld, H.; DeLaere, B.; Dirix, L.; Van Soest, R.; Lolkema, M.; Martens, J.; Van Weerden, W.; Jenster, G.; Foekens, J.; De Wit, R.; Sleijfer, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 258 Macrocytosis as a potential parameter associated with outcome in the treatment with tyrosine kinase inhibitors. (September 2015) Authors: Mathijssen, R.; Kloth, J.; Hamberg, P.; Mendelaar, P.; Dulfer, R.; Van der Holt, B.; Wiemer, E.; Kruit, W.; Sleijfer, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 305 Influencing sorafenib disposition by blocking hepatocellular sorafenib-glucuronide uptake with rifampin in mice and humans. (September 2015) Authors: Bins, S.; Van Doorn, L.; Gibson, A.; Hu, S.; Li, L.; Vasilyeva, A.; Hamberg, P.; Eskens, F.; De Bruijn, P.; Sparreboom, A.; Mathijssen, R.; Baker, S. Journal: European journal of cancer Issue: Volume 51(2015)Supplement 3 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer. Issue 17 (November 2015) Authors: van Soest, R.J.; Nieuweboer, A.J.M.; de Morrée, E.S.; Chitu, D.; Bergman, A.M.; Goey, S.H.; Bos, M.M.; van der Meer, N.; Hamberg, P.; de Wit, R.; Mathijssen, R.H.J. Journal: European journal of cancer Issue: Volume 51:Issue 17(2015:Nov.) Page Start: 2562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗